The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement, Cancer Research Heroes PICI Celebrates Carl H. June, MD Announcement, Our Impact PICI Network Researchers at SITC Spring Scientific Announcement, Cancer Research Heroes PICI Honors CAR T-cell Pioneer Carl H. June, MD Announcement, Our Impact PICI Network Researchers at #KSCancerImmuno23 Announcement PICI Network Presenters at #KScelltherapy23 Our Impact 2022 Year in Review Announcement PICI Network Researchers to Present at #ASH22